European Statistical Meeting on Analysis of Safety Data in Clinical Trials

Friday 23rd June 2017

Venue: Astellas Pharma Europe B.V., Sylviusweg 62, 2333BE Leiden, Netherlands

Safety data are the most common and one of the most important type of data collected in clinical trials. However, in general, the emphasis is on the efficacy data. In this meeting, we will take a look at various aspects of safety data in a clinical trial. Colleagues from industry, academia and regulatory agencies will come together to discuss latest developments for statistical analysis of adverse events, current practices in the conduct of data monitoring committees, and related topics on safety data in clinical trials. We will also hear thoughts on personalized safety analyses.

Confirmed speakers include Maria Costa (GSK), Adam Crisp (GSK), Johanna Gillhaus (or colleague, Pfizer), Bernd Heinen (JMP), Kit Roes (University of Utrecht), Gerd Rosenkranz (University of Vienna), and Robert Snijder (Astellas).

 

For further information please download the event programme below:

For information regarding the scientific content, contact:

Axel Krebs-Brown
Tel: +31 (0)71 545 5968
axel.krebs-brown@astellas.com